AUS
NZ
UK
CA
USA
IND
Highlights
- Acquisition expands comprehensive biobank services for clinical research.
- hVIVO PLC (HVO) secures advanced temperature-controlled storage solutions.
- Integration of Cryostore enhances operational capabilities in the biotechnology sector.
The pharmaceutical and biotechnology sectors experience significant shifts through the adoption of advanced biobank solutions. Companies operating within these fields focus on refining clinical trial support and research methodologies. Emphasis on secure and efficient storage for biological samples has become a cornerstone for successful clinical operations, as these sectors continue to evolve with technological advancements.
hVIVO PLC’s Strategic Expansion
hVIVO PLC (LSE:HVO), recognized for expertise in clinical services and human challenge trials, has completed the acquisition of Cryostore, a specialist in temperature-controlled storage for clinical and biological samples. The integration of Cryostore, based in Greenwich, represents a notable expansion of the hLAB services. This move reinforces the company’s commitment to delivering comprehensive laboratory support, thereby broadening the range of available services within clinical research environments.
Enhanced Storage Capabilities
The acquisition brings together a longstanding collaboration between hVIVO PLC and Cryostore, building on a history of joint efforts that span many years. Cryostore’s well-established reputation in managing temperature-sensitive storage assets now supports an expanded service offering. The facilities, comprising multiple storage units and ample storage space, equip hVIVO PLC with enhanced capabilities to manage a diverse portfolio of biological samples. This integration ensures that storage solutions meet the demanding requirements of clinical trials and research studies.
Expanded Client Service Offering
A key advantage of incorporating Cryostore into hVIVO’s operations lies in the broadened service portfolio. hVIVO PLC, already known for conducting human challenge trials and clinical research, now benefits from an integrated system that addresses extensive storage needs over extended research timelines. This advancement enables a more robust approach to managing biological samples, supporting activities that span from early-phase studies to more extensive research projects. Enhanced storage options contribute to improved service efficiency, meeting the demands of clinical research while upholding stringent quality standards.
Operational and Financial Implications
The acquisition not only strengthens the operational framework of hVIVO PLC but also consolidates the company’s market position in the biotechnology sector. Cryostore’s established regulatory certifications and effective operational protocols offer immediate advantages by streamlining processes within the clinical services division. Integration efforts focus on harmonizing Cryostore’s capabilities with other components of hVIVO’s portfolio. This alignment supports efficient service delivery and reinforces the company’s commitment to operational excellence within a competitive research landscape.
